Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy

MLA

Dong Hun Kim, et al. “Synergistic Anticancer Effect of Acteoside and Temozolomide-Based Glioblastoma Chemotherapy.” International Journal of Molecular Medicine, vol. 43, no. 3, July 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30e5d50906cc97258a625c6cd2a9a745&authtype=sso&custid=ns315887.

APA

Dong Hun Kim, Minho Moon, Dae Eun Choi, Jwa‑Jin Kim, Gun‑Hwa Kim, Tae Woong Hwang, Jae Ho Park, Kyung Ah Yoon, Tae Won Jang, & Da Bi Kim. (2018). Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy. International Journal of Molecular Medicine, 43(3).

Chicago

Dong Hun Kim, Minho Moon, Dae Eun Choi, Jwa‑Jin Kim, Gun‑Hwa Kim, Tae Woong Hwang, Jae Ho Park, Kyung Ah Yoon, Tae Won Jang, and Da Bi Kim. 2018. “Synergistic Anticancer Effect of Acteoside and Temozolomide-Based Glioblastoma Chemotherapy.” International Journal of Molecular Medicine 43 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....30e5d50906cc97258a625c6cd2a9a745&authtype=sso&custid=ns315887.